Madrigal Pharmaceuticals (MDGL) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

MDGL is expected to report earnings to -707 cents per share on November 06

Madrigal Pharmaceuticals MDGL Stock Earnings Reports

Q3'24

Est.

$-7.08

Q2'24

Beat

by $0.38

Q1'24

Missed

by $1.09

Q4'23

Missed

by $0.44

Q3'23

Missed

by $0.44

The last earnings report on August 07 showed earnings per share of -709 cents, beating the estimate of -748 cents. With 253.58K shares outstanding, the current market capitalization sits at 4.61B.

View a ticker or compare two or three

Compare

MDGL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MDGL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MDGL (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

200 Barr Harbor Drive

Phone

+1 267 824-2827

Employees

276

Web

http://www.madrigalpharma.com